Glucose transporter 3 performs a critical role in mTOR-mediated oncogenic glycolysis and tumorigenesis

Author：          

Publisher： Spandidos Publications

E-ISSN： 1792-1082|9|6|2809-2814

ISSN： 1792-1074

Source： Oncology Letters, Vol.9, Iss.6, 2015-01, pp. : 2809-2814

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

[Retracted] Glucose transporter 3 performs a critical role in mTOR-mediated oncogenic glycolysis and tumorigenesis

By Zhang Yanbin   Wei Can   Xi Junhua   Tang Zhiguo   Liang Chaozhao  

Oncology Letters, Vol. 10, Iss. 5, 2015-11 ,pp. : 3332-3332

Spandidos Publications

Access to resources Recommend Favorite

Lactate promotes resistance to glucose starvation via upregulation of Bcl-2 mediated by mTOR activation

By  

Oncology Reports, Vol. 33, Iss. 2, 2015-01 ,pp. : 875-884

Spandidos Publications

Access to resources Recommend Favorite

Role of mTOR in Hematological Malignancies

By  

Current Cancer Therapy Reviews, Vol. 4, Iss. 3, 2008-08 ,pp. : 211-218

Bentham Science Publishers

Access to resources Recommend Favorite

Patient-derived xenografts reveal limits to PI3K/mTOR- and MEK-mediated inhibition of bladder cancer

By Cirone Pasquale   Andresen Catharine   Eswaraka Jeetendra   Lappin Patrick   Bagi Cedo  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 525-538

Springer Publishing Company

Access to resources Recommend Favorite

The mTOR inhibitor AZD8055 inhibits proliferation and glycolysis in cervical cancer cells

By              

Oncology Letters, Vol. 5, Iss. 2, 2013-01 ,pp. : 717-721

Spandidos Publications

Access to resources Recommend Favorite